Corteva, Inc. $CTVA Shares Acquired by Entropy Technologies LP

Entropy Technologies LP lifted its holdings in Corteva, Inc. (NYSE:CTVA) by 1,199.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 87,874 shares of the company’s stock after acquiring an additional 81,114 shares during the quarter. Entropy Technologies LP’s holdings in Corteva were worth $5,943,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Empirical Finance LLC boosted its holdings in Corteva by 0.6% in the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after purchasing an additional 153 shares during the last quarter. Fox Run Management L.L.C. raised its stake in shares of Corteva by 5.1% during the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after buying an additional 164 shares during the last quarter. IFG Advisory LLC lifted its holdings in shares of Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock valued at $660,000 after buying an additional 166 shares during the period. United Community Bank boosted its stake in shares of Corteva by 10.5% in the third quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after buying an additional 176 shares during the last quarter. Finally, Binnacle Investments Inc boosted its stake in shares of Corteva by 54.7% in the second quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after buying an additional 181 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on CTVA shares. Mizuho lifted their price target on Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a research report on Tuesday, February 17th. Wells Fargo & Company raised their price objective on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Royal Bank Of Canada increased their price target on shares of Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average target price of $82.90.

Corteva Stock Up 1.4%

Shares of NYSE CTVA opened at $79.76 on Friday. The firm has a market cap of $53.64 billion, a price-to-earnings ratio of 50.48, a price-to-earnings-growth ratio of 2.69 and a beta of 0.72. The company’s 50-day simple moving average is $73.88 and its 200-day simple moving average is $69.20. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. The company’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.